What we do

Provide a solution for strengthening member’s health in society.
We develop health solution including digital therapeutics.

Digital Therapeutics

Digital therapeutics is terminology combined ‘Digital technology’ and ‘Therapeutics technology’ evidence based in industry field.

*Source: Marc et al, Digital technology and the future of health system

 
 

S-Alpha Therapeutics

S-Alpha Therapeutics, Inc. is a company that researches and develops health solution including digital therapeutics. We have discovered disruptive technology of treatment methods for highly unmet Medical need disease area. By developing therapeutic devices in the world, we strive to provide a solution to the disease to members of society.

 

Our story

S-Alpha Therapeutics, Inc. researches, develops, and moves forward digital therapeutics.

2024
03
ISO13485:2016 Quality System Certifications
2023
12
'SAT-001', obtained New Excellent Technology(NET) certification from the MOTIE
11
Renewal of GMP Certification
2022
12
Designation of MySATY-NUN(SAT-001) as an Innovative Medical Device in South Korea
2021
11
Established an US subsidiary
2020
12
Join Digital Therapeutics Alliance(DTA) Membership
11
Certification of conformity with medical device manufacturing and quality control standards (GMP)
03
Enterprise-affiliated Laboratory Certification
02
Venture Business Certification
2019
07
S-Alpha Therapeutics, Inc. Founded

Our Team

  • SEUNGEUN CHOI

    SEUNGEUN CHOI

    CHIEF EXECUTIVE OFFICER, M.D., Ph.D.

    -Translational Medicine, Immunology Specialist

    -Surgeon, Medicine

  • MYUNGJUN KIM

    CHIEF MEDICAL OFFICER, M.D., Ph.D.

    -Clinical/Medical General

    -Ophthalmology Clinic-Director of Renew Seoul

    -Ophthalmologist, Medicine

  • YONGSUN LEE

    CHIEF STRATEGY OFFICER, US OFFICER, Ph.D.

    -US Clinical/Operation General

    -Translational Medicine, Technology Management Specialist

    -Biochemistry

  • CHIHOON LEE

    CHIEF PLANNING OFFICER, M.S.

    -SW UI/UX Expert

    -Industrial Engineering

    -SW Planning General

  • Younghee Lee

    Principal investigator

    -Clinical/Medical General

    -Rehabilitation Medicine Specialist

    -Sports Medicine Specialist

    -Professor Emeritus, Yonsei University

  • Yangha Cho

    ADVISOR

    - Drug research and development

    - a medical device specialist

    - Dongguk University - Guest Professor

  • ADVISOR

    JACK W. MOORMAN

    ADVISOR, M.S.

    -Co-Founder, US-Japan Medtech Frontiers 

    -Chairman, U.S. - Japan Healthcare Council

    -Visiting Faculty Member, Graduate School of Medicine, Osaka University, Japan

    -Member of Stanford SPARK Advisors

    -Partner, Nichibei Advisors, LLC

    -Serial entrepreneur

    -Medical Device Inventor

Become a partner

If you would like to partner with us, please complete the information as follows and we’ll be in touch shortly.